DUBLIN--(BUSINESS WIRE)--The "Virtual Clinical Trials Market Research Report by Study Design, by Implication, by State - United States Forecast to 2027 - Cumulative Impact of COVID-19" report has been added to ResearchAndMarkets.com's offering.
The United States Virtual Clinical Trials Market size was estimated at USD 403.90 million in 2020, is expected to reach USD 519.10 million in 2021, and is projected to grow at a CAGR of 24.99% to reach USD 1,925.07 million by 2027.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Virtual Clinical Trials Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the United States Virtual Clinical Trials Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the United States Virtual Clinical Trials Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the United States Virtual Clinical Trials Market?
4. What is the competitive strategic window for opportunities in the United States Virtual Clinical Trials Market?
5. What are the technology trends and regulatory frameworks in the United States Virtual Clinical Trials Market?
6. What is the market share of the leading vendors in the United States Virtual Clinical Trials Market?
7. What modes and strategic moves are considered suitable for entering the United States Virtual Clinical Trials Market?
Key Topics Covered:
1. Preface
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges
5.2. Cumulative Impact of COVID-19
6. Virtual Clinical Trials Market, by Study Design
6.1. Introduction
6.2. Expanded Access Trials
6.3. Interventional Trials
6.4. Observational Trials
7. Virtual Clinical Trials Market, by Implication
7.1. Introduction
7.2. Cardiovascular Disease
7.3. Oncology
8. California Virtual Clinical Trials Market
9. Florida Virtual Clinical Trials Market
10. Illinois Virtual Clinical Trials Market
11. New York Virtual Clinical Trials Market
12. Ohio Virtual Clinical Trials Market
13. Pennsylvania Virtual Clinical Trials Market
14. Texas Virtual Clinical Trials Market
15. Competitive Landscape
15.1. FPNV Positioning Matrix
15.1.1. Quadrants
15.1.2. Business Strategy
15.1.3. Product Satisfaction
15.2. Market Ranking Analysis
15.3. Market Share Analysis, By Key Player
15.4. Competitive Scenario
15.4.1. Merger & Acquisition
15.4.2. Agreement, Collaboration, & Partnership
15.4.3. New Product Launch & Enhancement
15.4.4. Investment & Funding
15.4.5. Award, Recognition, & Expansion
16. Company Usability Profiles
16.1. AiCure LLC
16.2. Clinical Ink By GI Partners
16.3. CliniOps, Inc
16.4. Covance Inc
16.5. CRF Health By Genstar Capital
16.6. ERT
16.7. Everest Global, Inc
16.8. ICON PLC
16.9. IQVIA
16.10. LEO Innovation Lab
16.11. Medable, Inc.
16.12. Medidata Solutions
16.13. Medpace
16.14. Navitas Life Sciences, Inc.
16.15. Neoteryx, LLC
16.16. Oracle Corporation
16.17. Parexel International
16.18. Pfizer Inc.
16.19. Science 37
16.20. Tenthpin Management Consultants AG
16.21. VirTrial, LLC
17. Appendix
For more information about this report visit https://www.researchandmarkets.com/r/9kc5ee
